0001839882-23-034238.txt : 20231220 0001839882-23-034238.hdr.sgml : 20231220 20231220113043 ACCESSION NUMBER: 0001839882-23-034238 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 EFFECTIVENESS DATE: 20231220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Etheros Pharmaceuticals Corp. CENTRAL INDEX KEY: 0002005132 ORGANIZATION NAME: IRS NUMBER: 883959754 STATE OF INCORPORATION: DE FISCAL YEAR END: 1230 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500243 FILM NUMBER: 231500356 BUSINESS ADDRESS: STREET 1: 111 10TH AVE S STREET 2: STE 110 CITY: NASHVILLE STATE: TN ZIP: 37203 BUSINESS PHONE: (615) 212 9695 MAIL ADDRESS: STREET 1: 111 10TH AVE S STREET 2: STE 110 CITY: NASHVILLE STATE: TN ZIP: 37203 D 1 primary_doc.xml X0708 D LIVE 0002005132 Etheros Pharmaceuticals Corp. 111 10TH AVE S STE 110 NASHVILLE TN TENNESSEE 37203 615-212-9695 DELAWARE None None Corporation true 2022 John William Scannell 111 10th Ave S Ste 110 Nashville TN TENNESSEE 37203 Executive Officer Director Marc Feldmann 111 10th Ave S Ste 110 Nashville TN TENNESSEE 37203 Director Laura Dugan 111 10th Ave S Ste 110 Nashville TN TENNESSEE 37203 Director Francis Knuettel 111 10th Ave S Ste 110 Nashville TN TENNESSEE 37203 Director Subhasish Chakraborty 111 10th Ave S Ste 110 Nashville TN TENNESSEE 37203 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2023-02-20 false true Simple agreement for future equity (SAFE) false 25000 775000 775000 0 Offering is now closed. false 5 0 0 350000 true Part of the proceeds have been or will be used to pay a salary plus benefits to an officer of the company and certain other compensation to directors and officers. false Etheros Pharmaceuticals Corp. /s/ John William Scannell John William Scannell CEO 2023-12-20